课题基金 / 基金详情

TIM-mediated Inhibition of HIV Release: Cooperation with SERINC and Antagonism by Nef

TIM-mediated Inhibition of HIV Release: Cooperation with SERINC and Antagonism by Nef
TIM 介导的 HIV 释放抑制:与 SERINC 的合作和 Nef 的拮抗
批准号:
10242695
负责人:
Shan-Lu Liu
金额:
$33.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-01 至 2024-08-31

项目摘要

项目成果

Shan-Lu Liu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The majority of antiviral restriction factors are interferon (IFN) inducible, and are thus collectively referred to as IFN-stimulated genes (ISGs); many, however, are NOT directly regulated by IFN and remain poorly characterized. Notably, some of these cellular factors are known to modulate lipids and/or membrane properties, thereby disrupting the replication of HIV and other viruses. Two recent examples from this category are TIM (T- cell immunoglobulin and mucin domain) and SERINC (serine incorporator) family proteins, which directly interact with or possibly regulate the synthesis of phosphatidylserine (PS), thus inhibiting HIV release or infectivity. Interestingly, our preliminary data and two recent reports published in Nature showed that the lentiviral Nef proteins effectively antagonize the restriction by TIMs and SERINCs. Moreover, we have recently observed that SERINC proteins potentiate the ability of TIM-1 to block HIV-1 release and that SERINCs do this by stabilizing the TIM expression in the viral producer cells. In this application, we propose to test several novel hypotheses that address the possible link between TIM, SERINC, PS and Nef. Aim 1 will determine how HIV-1 Nef antagonizes TIM-mediated inhibition of viral release through modulating the synthesis and trafficking of TIM-1 and PS. Aim 2 will focus on understanding of the role of endogenous SERINC proteins in CD4+ T cells that regulates the TIM expression and stability, as well as in modulating lipids in the viral producer cell and viral particles, collectively contributing to the inhibition of HIV-1 release and replication. Aim 3 will define the molecular interplay between SERINC and TIM proteins in viral producer cells, and dissect how HIV-1 Nef protein down- modulates this process to promote HIV-1 production and infection. Results from the proposed experiments will provide novel and unified mechanistic insights into the interplay between TIM, SERINC and HIV Nef, and will enhance our understanding of virus-host interaction and AIDS pathogenesis.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1073/pnas.2111400119
发表时间: 2022-01-04
期刊: Proceedings of the National Academy of Sciences of the United States of America
影响因子: 11.1
作者: [Zeng C, Evans JP, King T, Zheng YM, Oltz EM, Whelan SPJ, Saif LJ, Peeples ME, Liu SL]
通讯作者: Liu SL
DOI: 10.1016/j.jbc.2021.100847
发表时间: 2021-07
期刊: The Journal of biological chemistry
影响因子: --
作者: [Evans JP, Liu SL]
通讯作者: Liu SL
CD4-Dependent Modulation of HIV-1 Entry by LY6E.
LY6E 对 HIV-1 进入的 CD4 依赖性调节。
DOI: 10.1128/jvi.01866-18
发表时间: 2019
期刊: Journal of virology
影响因子: 5.4
作者: [Yu,Jingyou, Liang,Chen, Liu,Shan-Lu]
通讯作者: Liu,Shan-Lu
DOI: 10.1126/scisignal.abc7611
发表时间: 2021-09-14
期刊: SCIENCE SIGNALING
影响因子: 7.3
作者: [Zeng, Cong, Waheed, Abdul A., Li, Tianliang, Yu, Jingyou, Zheng, Yi-Min, Yount, Jacob S., Wen, Haitao, Freed, Eric O., Liu, Shan-Lu]
通讯作者: Liu, Shan-Lu
IFITM-mediated Inhibition of HIV Infection and Viral Countermeasures
  • 批准号:
    9376203
  • 项目类别:
  • 资助金额:
    $36.3万
  • 财政年份:
    2017
  • 负责人:
    Shan-Lu Liu
  • 依托单位:
IFITM-mediated Inhibition of HIV Infection and Viral Countermeasures
  • 批准号:
    8991472
  • 项目类别:
  • 资助金额:
    $34.1万
  • 财政年份:
    2014
  • 负责人:
    Shan-Lu Liu
  • 依托单位:
IFITM-mediated Inhibition of HIV Infection and Viral Countermeasures
  • 批准号:
    8730947
  • 项目类别:
  • 资助金额:
    $35.46万
  • 财政年份:
    2014
  • 负责人:
    Shan-Lu Liu
  • 依托单位:
Inhibition of Ebolavirus Entry by IFITM2 Protein
  • 批准号:
    8702561
  • 项目类别:
  • 资助金额:
    $22.61万
  • 财政年份:
    2014
  • 负责人:
    Shan-Lu Liu
  • 依托单位:
海外基金